Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 49 of 60 found articles
 
 
  Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial
 
 
Title: Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial
Author: Catenacci, Daniel V T
Tebbutt, Niall C
Davidenko, Irina
Murad, André M
Al-Batran, Salah-Eddin
Ilson, David H
Tjulandin, Sergei
Gotovkin, Evengy
Karaszewska, Boguslawa
Bondarenko, Igor
Tejani, Mohamedtaki A
Udrea, Anghel A
Tehfe, Mustapha
De Vita, Ferdinando
Turkington, Cheryl
Tang, Rui
Ang, Agnes
Zhang, Yilong
Hoang, Tien
Sidhu, Roger
Cunningham, David
Appeared in: Lancet oncology
Paging: Volume 18 (2017) nr. 11 pages 1467-1482
Year: 2017
Contents:
Publisher: Elsevier Ltd
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 49 of 60 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands